Most patients with diabetes have little or no retinopathy on initial examination. Tracking the long-term outcomes of these patients may increase our understanding of how to best provide follow-up treatment.
R etinopathy screening is a cornerstone in the health care management of patients with diabetes and central to preserving vision 1, 2 ; however, significant difficulties remain in achieving appropriate ophthalmic care for many patients. Telemedicine and teleophthalmology programs improve diabetic retinopathy detection and represent an increasingly popular means to help offset the increasing demand for diabetic retinal screening. [1] [2] [3] [4] Several methods of fundus photography have been used for teleophthalmology programs. The increased peripheral retinal visualization afforded by ultrawide field photography allows for increased detection of nondiabetic peripheral retinal changes and can result in higher grading of diabetic retinopathy severity compared with traditional nonmydriatic fundus photographs 1, 2, 5, 6 ; however, it remains unclear whether this alters practical clinical outcomes.
Although the importance of screening eye examinations is well established, the follow-up interval for patients remains sub judice. The American Academy of Ophthalmology recommends a minimum of yearly screening examinations, with shorter intervals recommended for those with increasing severity of diabetic retinopathy. The possibility of screening low-risk patients every 2 years has been advocated. 7 An ideal screening interval would detect patients who require intervention to help prevent vision loss while limiting the number of unnecessary examinations.
Methods
The incidence of initiating retinal interventions in patients with minimal or no baseline diabetic retinopathy during 2 years was examined in this retrospective cohort study. The diabetic retinopathy telemedicine screening program at the Kaiser Permanente Southern California's Eye Monitoring Center has been previously described and validated. 3 Screening photographs consisted of two 45°fundus photographs: one centered on the optic nerve and one on the macula. Results were reviewed by a vitreoretinal specialist. Patients with moderate retinopathy or worse, including those with macular exudates, were referred for clinical evaluation. All the patients belong to the same integrated health care network, which includes primary care physicians and specialists, and any interventions rendered can be monitored through electronic medical records. Kaiser Permanente Southern California's Institutional Review Board granted approval for this study. Informed consent was waived by the institutional review board because the research involves no more than minimal risk to participants. Patients who received initial screening photographs in 2012 and who were graded as having minimal or no retinopathy and had at least 2 years of follow-up were included in this study. The medical records of patients with minimal or no retinopathy were cross-referenced with Current Procedural Terminology codes used for intravitreal injections, retinal lasers, and pars plana vitrectomy. Identified patients then had their medical records manually reviewed; the clinical indication and type of interventions were subsequently categorized. Vitrectomies that were performed at the time of cataract surgery, to remove retained lens fragments, or related to trauma were excluded.
Statistical Analysis
Descriptive analyses were performed to characterize the target population and to provide counts of interventions among patients with minimal or no retinopathy at baseline. Incidence rate of interventions per person-year were calculated. Eleven patients without baseline retinopathy required the initiation of treatment for complications of diabetic retinopathy, and 44 patients required an intervention because of conditions not directly related to diabetic eye disease in the 2 years after their baseline photographs ( Table 1) . This rate represents 0.000079 patients (or 1 of 12 660) per year requiring intervention for diabetic retinopathy and 0.000316 patients (or 1 of 3165) per year requiring interventions for nondiabetic conditions among those without baseline retinopathy. Eleven patients with minimal retinopathy on initial screening photographs required the initiation of treatment related to diabetic retinopathy (1 of 1784 or 0.000561 patients per year), and 5 patients required intervention for nondiabetic conditions (1 of 3924 or 0.000255 patients per year) during 2 years ( Table 2) .
Results
The most common intervention for treatment of diabetic retinopathy was panretinal photocoagulation for proliferative diabetic retinopathy in patients with minimal (6 patients [0.06%]) and those without (5 patients [0.007%]) baseline retinopathy. Pars plana vitrectomy was the most common intervention not related to diabetic eye disease, with 42 patients (0.06%) without baseline retinopathy and 3 patients (0.03%) with minimal baseline retinopathy undergoing this procedure. The most common indications for pars plana vitrectomy were macular holes (with or without concurrent epiretinal membrane, n = 15 [0.02%]) and rhegmatogenous retinal detachments (n = 15 [0.02%]).
Key Points
Question What is the 2-year rate of retinal intervention in patients with minimal or no diabetic retinopathy on telemedicine screening?
Findings In this cohort study, 11 of 69 364 patients with no baseline retinopathy and 11 of 9811 patients with minimal baseline retinopathy required a retinal intervention because of diabetic eye disease within 2 years of the baseline evaluation.
Meaning The findings suggest that extending follow-up examinations for patients with minimal or no baseline diabetic retinopathy may be warranted because most may not need retinal intervention within 2 years of initial evaluation, provided this extension does not lead to worse follow-up in later years.
Discussion
The importance of diabetic retinopathy screening is well established; however, the ideal interval for evaluation remains unclear. In addition, the utility of expanded visualization of the peripheral retina is an area of interest given the increasing use of ultrawide field photography. Extending follow-up intervals in low-risk patients may help alleviate some of the strain on health care systems.
Silva et al 5 detected more choroidal nevi (6.9% vs 5.3%, P < .001), chorioretinal atrophy or scarring (1.3% vs 0.6%, P < .001), retinal tears (0.3% vs 0%, P < .001), lattice and peripheral degenerations (0.7% vs 0%, P < .001), and vitreous detachments and floaters (1.8% vs 0%, P < .001) with ultrawide field photographs compared with conventional nonmydriatic fundus photographs; however, the clinical importance of detecting these changes remains questionable because most do not necessitate treatment or a change in future diagnostic approach. More patients undergoing imaging with ultrawide field imaging were identified as having diabetic retinopathy (38.4% vs 33.8%, P < .001) and vision-threatening diabetic retinopathy (14.5% vs 11.9%, P < .001) than with conventional nonmydriatic fundus photographs in another series by Silva et al. 6 Although differences between imaging types in the studies by Silva et al 5, 6 were statistically significant, the percentage of affected patients and the absolute difference between photography methods were modest for most measures, raising the possibility that the practical utility of ultrawide field photographs would be limited for most patients. Some of the patients likely had peripheral findings that were not detected; however, not detecting these lesions appeared to be of limited consequence because most patients did not go on to require the required both PPV and laser, 1 patient required both PPV and injection, and 1 patient required PPV, laser, and injection. b Forty-four patients required intervention during first 2 years; 5 patients required both PPV and laser, and 1 patient required both PPV and injection. Three patients required interventions in both eyes (bilateral PPV) and were only counted once in the table. Intravitreal injection 3 (Anti-VEGF for ME) 2 (1 Anti-VEGF for postoperative ME, 1 anti-VEGF for exudative age-related macular degeneration) initiation of treatment. This finding suggests that the status of the far peripheral retinal is unlikely to change the clinical course for most patients during 2 years. The incidence of retinal intervention was used as an indirect measure of visually significant disease. Future investigations should help better refine screening intervals, potentially by factoring in additional variables to create more personalized risk stratification. Ultrawide field views of the retina confer several advantages and may represent the future standard care; however, transitioning to these cameras represents a significant cost for established practices and reading centers. Traditional fundus photography is likely sufficient in most patients, especially those who are found to have little or no retinopathy. At present, the role of ultrawide field photography in patients with diabetes is under active investigation. 8 
Limitations
A limitation of this study is the use of Current Procedural Terminology coding data to identify which patients underwent retinal procedures, which can lend itself to inaccuracies because of coding errors, as well as the descriptive nature of the analyses.
Conclusions
The results presented herein suggest that patients with minimal or no retinopathy are unlikely to require the initiation of retinal treatment for diabetic retinopathy within 2 years of screening, and as such, most patients may not benefit from an additional examination before the second year. Efforts to extend follow-up intervals would need to ensure that adherence at later years is not compromised. Most interventions were rendered for conditions not directly related to diabetic retinopathy. Additional study is required to determine the ideal screening intervals for patients with diabetes as well as the economic, clinical, and practical value to ultrawide field imaging. 
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